Evidence map›Paper›PMID 26348575›Full record

ArticleThe American journal of pathology2015

Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors.

Laura Mangiavini, Christophe Merceron, Elisa Araldi, Richa Khatri, Rita Gerard-O'Riley, Tremika L Wilson, George Sandusky, Jerome Abadie, Karen M Lyons, Amato J Giaccia and 1 more

Abstract read
In one paragraph

Article in The American journal of pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laura MangiaviniDepartment of Orthopaedic Surgery and the Division of Endocrinology, Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Division of Endocrinology, Department of Medicine, Indiana University, Indianapolis, Indiana; Endocrine Unit, Massachusetts General Hospital-Harvard Medical School, Boston, Massachusetts; Department of Orthopaedic and Traumatology, Milano-Bicocca University, Milan, Italy.
Christophe MerceronDepartment of Orthopaedic Surgery and the Division of Endocrinology, Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Division of Endocrinology, Department of Medicine, Indiana University, Indianapolis, Indiana; INSERM, UMRS 791-LIOAD, Centre for Osteoarticular and Dental Tissue Engineering, Group STEP (Skeletal Tissue Engineering and Physiopathology), Nantes, France; Faculty of Dental Surgery, l'Universite Nantes Angers le Mans (LUNAM), Nantes, France.
Elisa AraldiEndocrine Unit, Massachusetts General Hospital-Harvard Medical School, Boston, Massachusetts.
Richa KhatriEndocrine Unit, Massachusetts General Hospital-Harvard Medical School, Boston, Massachusetts.
Rita Gerard-O'RileyDivision of Endocrinology, Department of Medicine, Indiana University, Indianapolis, Indiana.
Tremika L WilsonDepartment of Orthopaedic Surgery and the Division of Endocrinology, Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Division of Endocrinology, Department of Medicine, Indiana University, Indianapolis, Indiana; Endocrine Unit, Massachusetts General Hospital-Harvard Medical School, Boston, Massachusetts.
George SanduskyDepartment of Pathology, School of Medicine, Indiana University, Indianapolis, Indiana.
Jerome AbadieOniris Animal Cancers, Models for Comparative Oncology Research (AMaROC), l'Universite Nantes Angers le Mans (LUNAM), Nantes, France.
Karen M LyonsDepartment of Orthopaedic Surgery, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California. Electronic address: klyons@mednet.ucla.edu.
Amato J GiacciaDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Center for Clinical Sciences Research, Department of Radiation Oncology, Stanford University, Stanford, California. Electronic address: giaccia@stanford.edu.
Ernestina SchipaniDepartment of Orthopaedic Surgery and the Division of Endocrinology, Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Division of Endocrinology, Department of Medicine, Indiana University, Indianapolis, Indiana; Endocrine Unit, Massachusetts General Hospital-Harvard Medical School, Boston, Massachusetts. Electronic address: eschipan@med.umich.edu.

Funding

Structure, Composition, & Histology Core - Core BP30AR069620 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KARL J JEPSEN · 2016 to 2026
$8.4M
HIF-1alpha, a Survival and Differentiation Factor for CartilageR01AR065403 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHIPANI, ERNESTINA · 2013 to 2017
$1.7M
NIAMS NIH HHS P30 AR069620NIAMS NIH HHS R01 AR065403
6 · The paper itself

Abstract

The hypoxia-inducible factor (Hif)-1α (Hif-1α) and Hif-2α (Epas1) have a critical role in both normal development and cancer. von Hippel Lindau (Vhl) protein, encoded by a tumor suppressor gene, is an E3 ubiquitin ligase that targets Hif-1α and Epas1 to the proteasome for degradation. To better understand the role of Vhl in the biology of mesenchymal cells, we analyzed mutant mice lacking Vhl in mesenchymal progenitors that give rise to the soft tissues that form and surround synovial joints. Loss of Vhl in mesenchymal progenitors of the limb bud caused severe fibrosis of the synovial joints and formation of aggressive masses with histologic features of mesenchymal tumors. Hif-1α and its downstream target connective tissue growth factor were necessary for the development of these tumors, which conversely still developed in the absence of Epas1, but at lower frequency. Human tumors of the soft tissue are a very complex and heterogeneous group of neoplasias. Our novel findings in genetically altered mice suggest that activation of the HIF signaling pathway could be an important pathogenetic event in the development and progression of at least a subset of these tumors.

Indexed as

Signal TransductionAnimalsBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1FibrosisHumansHypoxia-Inducible Factor 1, alpha SubunitMesenchymal Stem CellsMiceMice, Inbred C57BLMice, TransgenicSoft Tissue NeoplasmsSynovial MembraneVon Hippel-Lindau Tumor Suppressor ProteinBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1Hif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitVHL protein, mouseVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID26348575
PMCPMC5801489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.